References
- BARNEA, 0., 1994, Mathematical analysis of coronary autoregulation and vascular reserve in closed-loop circula-tion. Computers in Biomedical Research, 27, 263 —275.
- BEKKER, A., WOLK, S., TURNDORF, H., KRISTOL, D., and RITTER, A., 1996, Computer simulation of cerebrovascular circulation: assessment of intracranial hemodynamics dur-ing induction of anesthesia. Journal of Clinical Monitoring, 12, 433 — 444.
- TAKAOKA, H., TAKEUCHI, M., ODAKE, M., HAYASHI, Y, and HATA, K, 1993, Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricles Circulation, 87, 59–69.
- SUGA, H., and SAGAWA, K, 1974, Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circulation Research, 35, 117–126.
- MILNOR, W. R., 1989, Hemodynamics, 2nd edition, (Balti-more, Maryland: Williams & Wilkins), pp. 96–98.
- SUGA, H., YASUMURA, Y, NOZAWA, T., FUTAKI, S., and IGARASHI, Y, 1987, Prospective prediction of 02 consump-tion from pressure—volume area in dog hearts. Arnerican Journal of Physiology, 252, H1258—H1264.
- BELLAMY, R. F., 1987, Diastolic coronary artery pre ssure-flow relations in the dog. Circulation Research, 43, 92–101.
- MONRAD, E. S., and BAIM, D. S., 1986, Milrinone, dobuta-mine, and nitroprusside: comparative effects on hemody-namics and myocardial energetics in patients with severe congestive heart failure. Circulation, 73 (suppl III), 168–172.
- GROSSE, R., STRAIN, J., and GREENBERG, M., 1986, Systemic and coronary effects of intravenous milrinone and dobu-tamine in congestive heart failure. Journal of American College of Cardiology, 7, 1107–1113.
- ZELIS, R., and RAlm, S. F., 1982, Alterations in vasomotor tone in congestive heart failure. Progress in Cardiovascular Disease, 24, 437–459.
- FOWLER, M. B., ALDERMAN, E. L., and OESTERLE, S. N., 1984, Dobutamine and dopamine after cardiac surgery. Greater augmentation of myocardial blood flow with dobutamine. Circulation, 70 (Suppl 1), 103–106.
- LOEB, H. S., BREDAIUS, J., and GUNNAR, R. M., 1977, Superiority of dobutamine over dopamine for augmenta-tion of cardiac output in patients with chronic low output cardiac failure. Circulation, 55, 375–380.
- BENDERSKY, R., CHATTERJEE, W., and PARMLEY, W., 1981, Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics. American Journal of Cardiology, 48, 554–561.
- GILLESPIE, T. A., and AMBOS, H. D., 1977, Effects of dobutamine in patients with acute myocardial infarction. American Journal of Cardiology, 39, 588–594.
- POZEN, R. G., DIBIANco, R., and KATz, R. J., 1981, Myocardial and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease. Circula-tion, 63, 1279–1285.
- MAGER, G., and ICLocxE, R. K, 1991, Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure. American Heart Journal, 121, 1974–1983.
- JACQUEZ, J. A., 1996, Compartmental Analysis in Biology and Medicine (Ann Arbor, MI: BioMedware Press).
- GREENWAY, C. V., 1992, Mechanisms and quantitative assessment of drug effects on cardiac output with a new model of the circulation. Pharmacological Reivews, 37, 213 — 251.